Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Nonanal from fruits and vegetables promotes hair growth by increasing growth factors.

BeauTop helps hair grow by increasing certain growth factors.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

The study showed that brown planaria can be used to cheaply test if local plants can stop cell growth.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Androgenetic alopecia in women needs more research and better management strategies.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

No treatment fully prevents hair loss from chemotherapy yet.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.